ArticleAmerican journal of translational research2022
Cell-free fat extract protects septic lethality via restraining NLRP3 inflammasome activation.
Article in American journal of translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 citations in OpenAlex.
- Cell-Free Fat Extract (CEFFE) as a Versatile Cell-Free Biologic for Multitissue Regeneration: From Skin and Bone to Nerve, Reproductive, and Systemic Applications-A Comprehensive Review.BioMed research international · 2026Review
- Cell-free adipose extract inhibits hypertrophic scar formation through collagen remodeling and antiangiogenesis.Open medicine (Warsaw, Poland) · 2025Article
- Ozonated triglyceride protects against septic lethality via preventing the activation of NLRP3 inflammasome.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis is a dysregulated host response to infection with high mortality and current management cannot reach optimal remission. Previous studies have shown that cell-free fat extract (CEFFE) is a kind of bioactive extraction from adipose tissues and exhibits a potent anti-inflammatory effect on wound healing and inflammatory diseases. However, the potential role of CEFFE in sepsis remains unclear.
methodsCEFFE was extracted from healthy donors and was intraperitoneally injected into septic mice. The septic mice models were constructed using lipopolysaccharide (LPS), E. coli, and cecal ligation and puncture (CLP). The survival of septic mice was detected for 96 h and Kaplan-Meier analysis was used to analyze the differences of survival rates. Lung tissues that were collected from septic mice were subjected to HE staining to evaluate the extent of lung injury, and the mice serum was obtained for inflammasome-related cytokines detection. Moreover, peritoneal macrophages were extracted from C57 mice and treated with CEFFE and/or inflammasome activators. The level of IL-1β, IL-18, IL-6, and TNF-α was detected by ELISA, and the activation of NLRP3 were evaluated by Western Blot. Total mtDNA and mitochondrial permeability transition pore were determined to explore the mitochondrial dysfunction in the activation of NLRP3 inflammasome with or without CEFEE. Coimmunoprecipitation (Co-IP) assays were performed to confirm the mechanism of NLRP3 activation induced by CEFFE.
resultsCEFFE significantly improved the survival of sepsis mice and alleviate sepsis-induced lung injury. Moreover, CEFFE significantly decreased the level of inflammasome-cytokines (IL-1β and IL-18) but not the pro-inflammatory cytokines such as IL-6 and TNF-α. Moreover, CEFFE markedly suppressed the canonical activation of NLRP3 inflammasome without affecting inflammasomes NLRC4 and AIM2. Additionally, the non-canonical activation of NLRP3 inflammasome was significantly inhibited by CEFFE. CEFFE treatment attenuated the mtDNA outflow and the increase of mitochondrial permeability induced by both canonical and non-canonical pathway of NLRP3 inflammasome activation. The results of Co-IP assays revealed that CEFFE remarkably attenuated the oligomerization of ASC and inhibited the association between NLRP3 and ASC.
conclusionOur study revealed that CEFFE could significantly alleviate sepsis-related injuries possibly by suppressing NLRP3 inflammasome activation. CEFFE was a promising approach for sepsis treatment.
Indexed as
Identifiers
35958494PMC9360875W4291283795What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.